Literature DB >> 8358548

Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats.

G Grignaschi1, B Mantelli, C Fracasso, M Anelli, S Caccia, R Samanin.   

Abstract

1. The effect of the CCKA receptor antagonist, devazepide (100 mg kg-1) on meal parameters during the initial phase of the dark period was studied in free-feeding rats by use of a procedure for continuously monitoring feeding patterns. 2. In a second experiment, the effect of devazepide on the reduction in meal parameters induced by the 5-hydroxytryptamine (5-HT) releaser and uptake inhibitor, (+)-fenfluramine (1.5 mg kg-1) in 4 h food-deprived rats was examined. 3. The hypophagic effect of an intraperitoneal injection of cholecystokinin (CCK-8, 4 micrograms kg-1) was studied in rats treated with the 5-HT receptor antagonist, metergoline (1 and 2 mg kg-1). 4. Devazepide increased the size of the first meal in free-feeding, but not in 4 h food-deprived rats and partially antagonized the effect of (+)-fenfluramine on the size and duration of the first meal. The reduction in eating rate induced by (+)-fenfluramine was not modified by devazepide. No changes in (+)-fenfluramine or (+)-norfenfluramine levels were found in the brain of rats treated with devazepide. 5. The effect of CCK-8 on meal size was completely antagonized by 2 mg kg-1 metergoline. A significant interaction was also found between 2 mg kg-1 metergoline and CCK-8 as regards their effect on the inter-meal interval. 6. The results suggest a reciprocal interaction between 5-HT and CCK-8 in enhancing the satiating effect of food in rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8358548      PMCID: PMC2175705          DOI: 10.1111/j.1476-5381.1993.tb13596.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Differences between the anorexic actions of amphetamine and fenfluramine--possible effects on hunger and satiety.

Authors:  J E Blundell; C J Latham; M B Leshem
Journal:  J Pharm Pharmacol       Date:  1976-06       Impact factor: 3.765

2.  Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

Authors:  B E Evans; M G Bock; K E Rittle; R M DiPardo; W L Whitter; D F Veber; P S Anderson; R M Freidinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 3.  From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake.

Authors:  S Garattini; T Mennini; R Samanin
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

Review 4.  Functional correlates of serotonin 5-HT1 recognition sites.

Authors:  D Hoyer
Journal:  J Recept Res       Date:  1988

5.  Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat.

Authors:  J J Vanderhaeghen; F Lotstra; J De Mey; C Gilles
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

6.  Disposition of D-fenfluramine in lean and obese rats.

Authors:  C Fracasso; G Guiso; S Garattini; S Caccia
Journal:  Appetite       Date:  1988-02       Impact factor: 3.868

7.  Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.

Authors:  R S Chang; V J Lotti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Infusion of cholecystokinin between meals into free-feeding rats fails to prolong the intermeal interval.

Authors:  D B West; M R Greenwood; A C Sullivan; L Prescod; L R Marzullo; J Triscari
Journal:  Physiol Behav       Date:  1987

9.  Separate populations of cholecystokinin and 5-hydroxytryptamine-containing neuronal cells in the rat dorsal raphe, and their contribution to the ascending raphe projections.

Authors:  D van der Kooy; S P Hunt; H W Steinbusch; A A Verhofstad
Journal:  Neurosci Lett       Date:  1981-10       Impact factor: 3.046

10.  Disposition of (-)-fenfluramine and its active metabolite, (-)-norfenfluramine in rat: a single dose-proportionality study.

Authors:  R Spinelli; C Fracasso; G Guiso; S Garattini; S Caccia
Journal:  Xenobiotica       Date:  1988-05       Impact factor: 1.908

View more
  2 in total

1.  Role of cholecystokinin and central serotonergic receptors in functional dyspepsia.

Authors:  Andrew Seng Boon Chua; P W N Keeling; T G Dinan
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

Review 2.  Involvement of the Dorsal Vagal Complex in Alcohol-Related Behaviors.

Authors:  Bailey N Keller; Andras Hajnal; Kirsteen N Browning; Amy C Arnold; Yuval Silberman
Journal:  Front Behav Neurosci       Date:  2022-03-07       Impact factor: 3.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.